All payments made in the preview are in test mode. Read more
Sign in
Back to Atlas
APotentially durableStandard research/education caution
CMP-0047
Not approved; prohibited in sport

Epistane / Methylepitiostanol

Ergogenic / AAS

Dry/lean anabolic steroid supplement history

Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.

Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.

Mechanism & Use

Compound type
17α-alkylated AAS
Primary mechanism
DHT-derived AR agonist; A:A ratio not modern-validated
Primary market use
Designer supplement AAS

Pharmacology

Molecular weight (Da)
320.54
Oral bioavailability
Oral; 17α-alkylated
Half-life
~6 h (approx.)
Route tags
Route-dependent / verify
Evidence level
Supplement/doping literature
Clinical status
Not approved; prohibited in sport
Value-for-money score
3 / 10

Reported protocol signal

No popular protocol verified yet; keep as reference compound until protocol signal is added.

For orientation only. See disclaimer — always consult a licensed clinician before use.

Notes

Often sold as epistane/havoc; ratio claims vary and are not modern clinical indices.

Educational and organizational assistant matrix. Not medical advice.

BioChrysalis Atlas is an educational, organizational, and tracking asset. It does not provide medical advice, diagnosis, treatment, prescriptions, or individualized dosing instructions. Compound profiles, protocol notes, and dosage fields summarize publicly discussed or source-listed reference patterns and are not recommendations. Consult a qualified healthcare professional before starting, stopping, or modifying any compound, medication, or supplement protocol.

© BioChrysalis · Evolve · Ascend · Transcend